The measurement of pneumococcal carriage in the nasopharyngeal reservoir is subject to
potential confounders that include low-density and multiple-strain colonization. To compare …

Background. Pneumococcal conjugate vaccines (PCVs) prevent vaccine serotype (VT) invasive
disease; nonvaccine serotype (NVT) disease increases modestly. The impact of PCV on …

Background. Major advances in combat casualty care have led to increased survival of patients
with complex extremity trauma. Invasive fungal wound infections (IFIs) are an uncommon…

Background Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory
tract infections in children. We aimed to assess the safety and efficacy of an anti-RSV …

Infections have long been known to complicate care in patients after traumatic injury frequently
leading to excess morbidity and mortality. 1, 2 In no setting is this more well recognized …

Background The efficacy of public health measures to control the transmission of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not been well studied in young …

Background . Since the introduction of 7-valent pneumococcal conjugate vaccine (PCV7) in
the United States, rates of invasive pneumococcal disease have decreased in both …

Background. We assessed the impact of 12 years of pneumococcal conjugate vaccine (PCV7)
use on pneumococcal nasopharyngeal carriage and serotype-specific invasive disease …

Background . A 7-valent pneumococcal conjugate vaccine (PnCRM7) has been shown to
be highly effective in preventing invasive pneumococcal disease. Pneumococcal conjugate …

Background human rhinovirus (HRV) is a major cause of influenza-like illness (ILI) in adults
and children. Differences in disease severity by HRV species have been described among …